AMSTERDAM–(BUSINESS WIRE)–Avanzanite Bioscience B.V., une société pharmaceutique spécialisée en phase de commercialisation axée sur la mise sur le marché de nouveaux médicaments pour les maladies rares, a annoncé aujourd’hui que la Commission europée…
Author: Business Wire
US YUTIQ Market Size, Forecast, and Market Insights 2024-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US YUTIQ Market Size, Forecast, and Market Insight – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about YUTIQ for autoimmune uveitis in the US. A detailed pi…
National Vision Releases 2023 Sustainability Report
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the largest optical retail companies in the U.S., released its 2023 Sustainability Report, “A World Worth Seeing.” The report reflects continued progress across its Social, Employees, Environm…
ETSU Grant Enables Tennessee Public Libraries to Support Color Blind People with EnChroma Glasses
JOHNSON CITY, Tenn. & BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–ETSU Grant Enables Tennessee Public Libraries to Become First State to Loan EnChroma Glasses for Color Blindness at Public Libraries Via NIH Grant
Avanzanite Bioscience Reports European Commission's Authorisation of Orphan Medicinal Product AKANTIOR®
AMSTERDAM–(BUSINESS WIRE)– #innovation–Avanzanite Bioscience B.V., a commercial-stage specialty pharmaceutical company, focused on bringing novel medicines for rare diseases to market, announced today that the European Commission (EC) granted market…
$15+ Bn Contact Lenses Market by Material, Usage, Design, Application, Distribution Channel, Regions and Company Analysis 2024-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market Report by Material, Usage, Design, Application, Distribution Channel, Regions and Company Analysis 2024-2032” report has been added to ResearchAndMarkets.com’s offering. The publisher predicts that by…
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
GENEVA–(BUSINESS WIRE)–Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
GENEVA–(BUSINESS WIRE)–Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
LifeLink® of Georgia Encourages Organ Donors to Leave a Lasting Legacy
ATLANTA–(BUSINESS WIRE)–LifeLink of Georgia, one of five divisions of LifeLink® Foundation, is on a mission to inspire new organ donor registrations and celebrate those who have decided to save lives as a registered organ, eye, and tissue donor. Toda…
Alain Afflelou Relies on Informatica to Improve and Ensure Data Trust Across Global Franchises
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Informatica (NYSE: INFA), a leader in enterprise AI-powered cloud data management, today announced that Alain Afflelou, a top global franchise provider for optical and auditory solutions, is using Informatica’s AI…
Ikotek Helps Artha France Improve Autonomy for Blind and Visually Impaired People
SAN DIEGO–(BUSINESS WIRE)–Ikotek, the USA-headquartered global provider of original design manufacturing (ODM) for IoT, has announced a new partnership with Artha France, a specialist in inventing products for the visually impaired and blind. Artha F…
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and six months ended June 30, 2024 and provides a business update. “Revenue growth was driven by higher Avenova sales throu…
Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
New SuperX Sunglasses Deliver Color to the Extreme for Today’s Adventurer-Athletes
BERKELEY, Calif.–(BUSINESS WIRE)– #SuperXeyewear–New SuperX Sunglasses Deliver Color to the Extreme for Adventurer-Athletes with Color Vision Boosting Technology that Pushes the Boundaries of Science
Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported it…
RingIQ.ai Call Assistant Helps Optometrists Answer the Phone
HOUSTON–(BUSINESS WIRE)–RingIQ.ai has launched a new AI service to help answer patient phone calls. RingIQ.ai artificial intelligence learns individual office appointment policies, exam types, doctor’s schedules, pricing, insurance, location/driving …
LumiThera annuncia il primo codice CPT per segnalare la terapia di fotobiomodulazione nelle malattie della retina – un primo passo verso il rimborso
SEATTLE–(BUSINESS WIRE)–LumiThera, Inc., azienda produttrice di dispositivi medici che commercializza un trattamento di fotobiomodulazione (PBM) per i danni e le malattie oculari, ha annunciato oggi un nuovo codice CPT di categoria III che entrerà in…
PhotoPharmics Enrolls First 100 Participants in Groundbreaking Parkinson's Disease Trial
SALT LAKE CITY–(BUSINESS WIRE)– #medicaldevices–PhotoPharmics, a leader in neurodegenerative disease phototherapy, today announced the enrollment of the first 100 subjects in its Light for PD clinical trial. This marks a significant milestone in eva…
Eyeglasses Business Report 2024: Upgrades and Multiple Purchases in Developed Markets & Premiumization Trend and Affordable Luxury Aids Market Growth – Forecast to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyeglasses – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Eyeglasses is estimated at US$157.1 Billion in 2023 and is projected to reach US$234.4 Billio…
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and fi…